Lemmenmeier Sina, Boehm Ingrid
Department of Anaesthesiology, Hospital of Buelach, Buelach, Switzerland.
Department of Diagnostic, Interventional, and Pediatric Radiology, Inselspital, University of Bern, Bern, Switzerland.
Fundam Clin Pharmacol. 2025 Feb;39(1):e13045. doi: 10.1111/fcp.13045. Epub 2024 Nov 28.
There are discrepancies between guidelines of scientific societies and information of the package inserts of contrast media concerning breastfeeding following the application of a contrast agent to the mother.
The contents of different review articles reflect the opinion of scientific societies. Consequently, in clinical routine settings it is difficult to find the optimal advice for a breastfeeding woman and her baby.
Therefore, the paper carefully summarized important information dealing with the topic 'breastfeeding and contrast media' from the literature. Among other things, the paper focuses on topics that are not yet taken into account in other reviews (e.g. approval for breastfeeding women, contrast agents that have been analysed in human breast milk).
In this way, the review shows new aspects. It has been revealed that data concerning the amount of contrast agents in human breast milk as well as contrast medium absorption by the infants' intestine are sparse. Instead of them, a lot of speculations and incorrect conclusions do exist in the literature. Because studies are rare or missing, contrast media are not approved for breastfeeding women (off-label-use).
Although breastfeeding women 100% prefers a break from breastfeeding, in current decision-making processes, their preference plays a minor role. However, this should change in the future. In addition, it would be very important to inform breastfeeding women in the future about the missing data concerning 'breastfeeding and contrast media'.
在科学学会的指南与造影剂药品说明书中关于母亲使用造影剂后母乳喂养的信息之间存在差异。
不同综述文章的内容反映了科学学会的观点。因此,在临床常规环境中,很难为哺乳期妇女及其婴儿找到最佳建议。
因此,本文仔细总结了文献中关于“母乳喂养与造影剂”这一主题的重要信息。除其他事项外,本文重点关注其他综述中尚未考虑的主题(例如对哺乳期妇女的批准情况、已在人乳中分析的造影剂)。
通过这种方式,该综述展示了新的方面。已发现关于人乳中造影剂含量以及婴儿肠道对造影剂吸收的数据很少。相反,文献中存在许多猜测和错误结论。由于研究很少或缺失,造影剂未被批准用于哺乳期妇女(标签外使用)。
尽管哺乳期妇女100%倾向于暂停母乳喂养,但在当前的决策过程中,她们的偏好作用较小。然而,这在未来应该会改变。此外,未来告知哺乳期妇女关于“母乳喂养与造影剂”的缺失数据非常重要。